CRL EPS Estimates
Charles River Laboratories International, Inc.
$302.00
+$2.98(+1.00%)
60
Overall
60
Value
66
Tech
55
Quality
Market Cap
$14.42B
Volume
941.28K
52W Range
$146.20 - $333.30
Target Price
$317.44
CRL EPS estimates: the consensus estimate for Charles River Laboratories International, Inc.'s current fiscal year is $11.36 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRL EPS Estimates
- EPS estimate, current quarter
- $2.97
- EPS estimate, next quarter
- $3.30
- EPS estimate, current year
- $11.36
- EPS estimate, next year
- $12.64
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.91 |
| 2024 | $0.20 |
| 2023 | $9.27 |
| 2022 | $9.57 |
| 2021 | $7.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRL | $302.00 | +1.0% | 941.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Charles River Laboratories International, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW